欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/0892/001
药品名称Irinotecan Hydrochloride 20 mg/ml Concentrate for Solution for Infusion
活性成分
    • irinotecan 20.0 mg/ml
剂型Solution for injection
上市许可持有人Fresenius Kabi Austria GmbH Hafnerstrasse 36 8055 Graz Austria
参考成员国 - 产品名称Austria (AT)
互认成员国 - 产品名称
    • Ireland (IE)
    • United Kingdom (Northern Ireland) (XI)
      PL 18727/0040 - 0003
    • Denmark (DK)
    • Netherlands (NL)
    • Sweden (SE)
    • Norway (NO)
    • Lithuania (LT)
      Irinotecan Fresenius 20 mg/ml koncentratas infuziniam tirpalui
    • Hungary (HU)
      IRINOTECAN ACCORD 20 mg/ml koncentrátum oldatos infúzióhoz
    • Slovakia (SK)
      Irinotecan (20 mg/ml)
许可日期2008/09/11
最近更新日期2021/08/02
药物ATC编码
    • L01XX19 irinotecan
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase